Microbial endocrinology and infectious disease in the 21st century

Trends in Microbiology

Volumn 12, Issue 1, 2004, Pages 14-20

  Lyte, Mark ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b MINNESOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HORMONE; NORADRENALIN;

BACTERIAL GROWTH; BACTERIAL VIRULENCE; DISEASE ASSOCIATION; DISEASE COURSE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFECTION RISK; NEUROENDOCRINOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PURIFICATION; REVIEW; SEPSIS;

BACTERIA (MICROORGANISMS);

EID: 0347360213     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2003.11.004     Document Type: Article

References (61)

1. Yamashima T. Jokichi Takamine (1854-1922), the samurai chemist, and his work on adrenalin. J. Med. Biogr. 11:2003;95-102.
2. Renaud M., Miget A. Role favorisant des perturbations locales causees par l' adrenaline sur le developpement des infections microbiennes. C. R. Seances Soc. Biol. Fil. 103:1930;1052-1054.
3. Cooper E.V. Gas-gangrene following injection of adrenaline. Lancet. 247:1946;459-461.
4. Evans D.G., et al. The enhancement of bacterial infections by adrenaline. Br. J. Exp. Pathol. 29:1948;20-39.
5. LeRoith D., et al. Insulin or a closely related molecule is native to Escherichia coli. J. Biol. Chem. 256:1981;6533-6536.
6. Lenard J. Mammalian hormones in microbial cells. Trends Biochem. Sci. 17:1992;147-150.
7. LeRoith D. Vertebrate hormones and neuropeptides in microbes: evolutionary origin of intercellular communication. Martini L., Ganong W.F. Frontiers in Endocrinology. Vol. 8:1984;1-25 Raven Press.
8. Traub W.H., et al. Virulence of clinical and fecal isolates of Clostridium perfringens type A for outbred NMRI mice. Chemotherapy. 37:1991;426-435.
9. Santos J., Perdue M.H. Stress and neuroimmune regulation of gut mucosal function. Gut. 47:(Suppl 4):2000;49-51.
10. Lyte M. The role of microbial endocrinology in infectious disease. J. Endocrinol. 137:1993;343-345.
11. Costa M., et al. Anatomy and physiology of the enteric nervous system. Gut. 47:(Suppl 4):2000;15-19.
12. Lyte M., Ernst S. Catecholamine induced growth of gram negative bacteria. Life Sci. 50:1992;203-212.
13. Peterson P.K., et al. Stress and pathogenesis of infectious disease. Rev. Infect. Dis. 13:1991;710-720.
14. Lyte M., et al. Innate and adaptive immune responses in a social conflict paradigm. Clin. Immunol. Immunopathol. 57:1990;137-147.
15. Lyte M., Ernst S. Alpha and beta adrenergic receptor nvolvement in catecholamine-induced growth of gram-negative bacteria. Biochem. Biophys. Res. Commun. 190:1993;447-452.
16. Lyte M., et al. Production of an autoinducer of growth by norepinephrine cultured Escherichia coli O157:H7. FEMS Microbiol. Lett. 139:1996;155-159.
17. Lyte M., et al. Norepinephrine-induced expression of the K99 pilus adhesin of enterotoxigenic Escherichia coli. Biochem. Biophys. Res. Commun. 232:1997;682-686.
18. Lyte M., et al. Production of Shiga-like toxins by Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone norepinephrine. J. Lab. Clin. Med. 128:1996;392-398.
19. Benedict C.R., Grahame-Smith D.G. Plasma noradrenaline and sadrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q. J. Med. 47:1978;1-20.
20. Groves A.C., et al. Plasma catecholamines in patients with serious postoperative infection. Ann. Surg. 178:1973;102-107.
21. Jones S.B., et al. Plasma catecholamines during E. coli bacteremia in conscious rats. Am. J. Physiol. 254:1988;R470-R477.
22. Gruchow H.W. Catecholamine activity and infectious disease episodes. J. Human Stress. 5:1979;11-17.
23. Kovarik M.F., et al. Plasma catecholamines following cecal ligation and puncture in the rat. Circ. Shock. 22:1987;281-290.
24. Kopin I.J., et al. Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 325:1984;298-305.
25. Brehmer A., et al. Morphological classifications of enteric neurons-100 years after Dogiel. Anat. Embryol. (Berl.). 200:1999;125-135.
26. Aneman A., et al. Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepin-ephrine spillover. J. Clin. Invest. 97:1996;1640-1646.
27. Eisenhofer G., et al. Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab. 82:1997;3864-3871.
28. Jones S.L., Blikslager A.T. Role of the enteric nervous system in the pathophysiology of secretory diarrhea. J. Vet. Intern. Med. 16:2002;222-228.
29. Soderholm J.D., et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 123:2002;1099-1108.
30. Webster J.I., et al. Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc. Natl. Acad. Sci. U. S. A. 100:2003;5706-5711.
31. Uribe A., et al. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology. 107:1994;1259-1269.
32. de Champlain J. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine. Can. J. Physiol. Pharmacol. 49:1971;345-355.
33. Lyte M., Bailey M.T. Neuroendocrine-bacterial interactions in a neurotoxin-induced model of trauma. J. Surg. Res. 70:1997;195-201.
34. Yang S., et al. Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G1274-G1281.
35. Harris R.M., et al. Activity of phenolsulfotransferases in the human gastrointestinal tract. Life Sci. 67:2000;2051-2057.
36. Pitman R.M. Transmitter substances in insects: a review. Comp. Gen. Pharmacol. 2:1971;347-371.
37. Woods D.E., et al. Interaction of insulin with Pseudomonas pseudomallei. Infect. Immun. 61:1993;4045-4050.
38. LeRoith D., et al. Bacillus subtilis contains multiple forms of somatostatin-like material. Biochem. Biophys. Res. Commun. 127:1985;713-719.
39. Wood J.D., et al. Fundamentals of neurogastroenterology. Gut. 45:(Suppl 2):1999;II6-II16.
40. Yurdaydin C., et al. Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy. Brain Res. 679:1995;42-48.
41. Minuk G.Y. Gamma-aminobutyric acid (GABA) production by eight common bacterial pathogens. Scand. J. Infect. Dis. 18:1986;465-467.
42. Guthrie G.D., Nicholson-Guthrie C.S. Gamma-Aminobutyric acid uptake by a bacterial system with neurotransmitter binding characteristics. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7378-7381.
43. Balcar V.J. Presence of a highly efficient "binding" to bacterial contamination can distort data from binding studies. Neurochem. Res. 15:1990;1237-1238.
44. Gieldanowski J., et al. Pharmacological analysis of the adrenergic receptor for lipopolysaccharide-I of Shigella sonnei. Arch. Immunol. Ther. Exp. (Warsz.). 20:1972;951-957.
45. Freestone P.P., et al. The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J. Bacteriol. 182:2000;6091-6098.
46. Reissbrodt R., et al. Resuscitation of Salmonella enterica serovar typhimurium and enterohemorrhagic Escherichia coli from the viable but nonculturable state by heat-stable enterobacterial autoinducer. Appl. Environ. Microbiol. 68:2002;4788-4794.
47. Burton C.L., et al. The growth response of Escherichia coli to neurotransmitters and related catecholamine drugs requires a functional enterobactin biosynthesis and uptake system. Infect. Immun. 70:2002;5913-5923.
48. Freestone P.P., et al. Involvement of enterobactin in norepinephrine-mediated iron supply from transferrin to enterohaemorrhagic Escherichia coli. FEMS Microbiol. Lett. 222:2003;39-43.
49. Belay T., et al. Catecholamines and in vitro growth of pathogenic bacteria: enhancement of growth varies greatly among bacterial species. Life Sci. 73:2003;1527-1535.
50. Leinhardt D.J., et al. Plasma NE concentrations do not accurately reflect sympathetic nervous system activity in human sepsis. Am. J. Physiol. 265:1993;E284-E288.
51. Mobley P., Greengard P. Evidence for widespread effects of noradrenaline on axon terminals in the rat frontal cortex. Proc. Natl. Acad. Sci. U. S. A. 82:1985;945-947.
52. Sanders V.M., Munson A.E. Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 230:1984;183-192.
53. Andrade-Mena C.E. Inhibition of gamma interferon synthesis by catecholamines. J. Neuroimmunol. 76:1997;10-14.
54. Erami C., et al. Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H1577-H1587.
55. Nietfeld J.C., et al. Norepinephrine stimulates in vitro growth but does not increase pathogenicity of Salmonella choleraesuis in an in vivo model. Adv. Exp. Med. Biol. 473:1999;249-260.
56. Chen C., et al. Catecholamines modulate Escherichia coli O157:H7 adherence to murine cecal mucosa. Shock. 20:2003;183-188.
57. Alverdy J., et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann. Surg. 232:2000;480-489.
58. Hendrickson B.A., et al. Increased type 1 fimbrial expression among commensal Escherichia coli isolates in the murine cecum following catabolic stress. Infect. Immun. 67:1999;745-753.
59. Freestone P.P., et al. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock. 18:2002;465-470.
60. Sperandio V., et al. Bacteria-host communication: the language of hormones. Proc. Natl. Acad. Sci. U. S. A. 100:2003;8951-8956.
61. Lyte M., et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet. 361:2003;130-135.